Zhilong Huoxue Tongyu capsule inhibits hypertensive myocardial fibrosis via balancing TGF-β1/Smad3/Erbb4-IR/miR-29b pathway

Zhilong Huoxue Tongyu capsule inhibits hypertensive myocardial fibrosis via balancing TGF-β1/Smad3/Erbb4-IR/miR-29b pathway

Abstract Zhilong Huoxue Tongyu capsule (ZL) is wildly used as a Chinese patent medicine for the treatment of cardiovascular diseases. Clinical studies have found that it can significantly improve hypertension and heart failure. However, its precise molecular mechanisms remain incompletely understood...

Full description

Saved in:
Bibliographic Details
Main Authors: Qiuyu Liu, Dingshan Zhang, Raoqiong Wang, Shihan Sun, Yuanyuan Li, Zhenxun Wan, Yumei Qian, Xinrui Yang, Gang Luo, Mingtai Chen, Mengnan Liu
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Zhilong Huoxue Tongyu capsule
Hypertensive
Heart failure
Myocardial fibrosis
TGF-β1/Smad3/Erbb4-IR/miR-29b pathway
Online Access:https://doi.org/10.1038/s41598-025-10631-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-10631-9

Similar Items